I Practiced Internal Medicine For 22 Years. I Left Because I Couldn't Keep Telling Patients To "Just Monitor" A Liver That Was Quietly Failing.
What I found afterward is something I was never allowed to say from behind that desk — and it isn't what you'd expect.
Dr. Thomas Reeves, photographed after leaving full-time practice.
If someone has ever told you your liver enzymes are "a little elevated" — then told you to cut back, lose a few pounds, and come back in six months — I need you to read this before your next appointment.
For 22 years, that conversation was mine to have. Sit down, hand over the labs, deliver the line I'd delivered hundreds of times before: "It's mild. Let's keep an eye on it." Then move on to the next patient, because a follow-up on early fatty liver doesn't get more than eight or nine minutes on a modern schedule.
I said it so many times it stopped meaning anything to me. And for a long time, I didn't think hard enough about what happened to those patients in the six months between visits.
Then I started paying attention.
The Pattern I Wasn't Supposed to Notice
A handful of patients came back with numbers that had genuinely improved — and they weren't the ones who'd "tried the hardest" by any measure I could see on a chart. Most patients who followed the boilerplate advice to the letter still came back with the same numbers. Some came back worse.
So I started asking different questions. Not "are you cutting back on alcohol" — everyone says yes to that one, whether it's true or not. I asked what they were actually taking. What was sitting in their cabinet. What they'd tried and quietly given up on.
The answer surprised me. Milk thistle and turmeric came up constantly — from patients whose numbers had improved, and from patients whose numbers hadn't moved at all. Same ingredients on the label. Completely different outcomes. That didn't make sense to me until I stopped looking at what they were taking, and started looking at the form they were taking it in.
What Actually Separated Them
Curcumin — the active compound in turmeric — has one of the worst oral bioavailability profiles of any commonly used botanical. On its own, in a standard capsule, most of a dose never survives digestion intact. That's a documented pharmacology problem, not a fringe theory.
The patients whose numbers moved weren't taking more turmeric. They were taking it in a form — liquid, combined with a black pepper extract called piperine — that research shows can increase curcumin absorption by up to 2,000%. Piperine isn't another herbal add-on. It's the difference between a dose that actually reaches the liver and a dose that just passes through.
"Once I lined up years of bloodwork side by side, it wasn't subtle. I remember sitting at my desk after hours, looking at the same pattern over and over, thinking: wait a second — this isn't what I was trained to believe mattered."
Why I Couldn't Say Any of This From Behind That Desk
I want to be clear about something: I worked alongside excellent, caring physicians. I'm not describing a conspiracy or a villain. I'm describing an incentive structure that has nothing to do with anyone's character.
A liver enzyme panel is billable. A follow-up visit is billable. A prescription is billable. A twenty-minute conversation about bioavailability science for a $35 bottle with no NDC code, no insurance code, and no pharmaceutical rep behind it — that isn't. Hospital compliance policy doesn't allow a prescribing physician to formally recommend an off-label supplement stack, no matter how much literature backs it. And there's no formulary pathway for something that isn't patented, because there's no company positioned to fund it through one.
None of that makes the standard advice wrong. It just means the full picture never made it into the eight minutes I had with a patient. And the part that always bothered me most: I couldn't tell people what I was starting to suspect might actually move their numbers — because it wasn't "standard of care," even when I believed it was true.
The Investigation
After I left, I spent months going back through the literature the way I never could when I was seeing twenty patients a day — silymarin's hepatoprotective research, curcumin's effect on the inflammatory markers tied to fatty liver progression, the pharmacokinetics behind piperine's absorption multiplier. I cross-referenced all of it against 22 years of my own patients' bloodwork.
What I found confirmed what I'd already watched happen with my own eyes for over two decades. I just never had the freedom to act on it while I was still practicing.
What I Found
Why Your Doctor Hasn't Told You This
The Problems With "Just Monitor It" Nobody Discusses
The Progression Problem
Fatty liver is silent by design. Most people feel nothing until the disease has already progressed — by the time fatigue, bloating, or right-side discomfort show up, "monitoring" has usually already meant months or years of unaddressed progression.
The Medication Burden Problem
The same decade that brings elevated liver enzymes often brings a growing list of daily medications — statins, metformin, blood pressure prescriptions — nearly all of which are processed through the liver, adding to a workload that's already struggling.
The Absorption Problem
Most people who say "I already tried milk thistle" or "I already tried turmeric" didn't fail because the ingredients don't work. They failed because, in capsule form, almost none of what they swallowed ever reached their liver intact.
The Time Problem
"Let's recheck in six months" sounds cautious. In practice, it often means six more months of a slow decline before anyone intervenes with anything beyond a repeat blood draw.
My Assessment
I'm not in a position to write a prescription anymore, and that's the point — I'm not trying to sell you a treatment. I'm telling you what I'd tell a patient sitting across from me, if I still had that job and wasn't restricted from saying it.
If your liver enzymes have ever come back "mildly elevated," if you've already tried a milk thistle or turmeric capsule that didn't seem to do anything, or if you're simply over 50 and want to give your liver something that actually reaches it — the formula that changed how I think about this is OLVA's Milk Thistle + Curcumin Drops. Liquid delivery. Individually-dosed Black Pepper Extract — not buried inside a "proprietary blend" where you can't see the actual dose. Nothing else added that your liver has to process on top of everything it's already managing.
CHECK AVAILABILITY — 90-DAY GUARANTEE →What's In The Formula
OLVA Is Not Sold On Amazon, eBay, or In Any Retail Store
Because it's sold directly, there's no retail markup, no third-party reseller, and no risk of an expired or counterfeit bottle from an unauthorized listing. The exact formula described in this article is only available through the official website.
Try It Risk-Free For 90 Days
If you don't notice a difference in how your body handles it, email support@tryolva.com and you'll be refunded in full — whether or not you've opened or used the bottle. No complicated process, no fine print.
Made in small batches — demand spikes during promotions like this one.
What Patients Like You Are Saying
Real reviews from people who switched from capsules to OLVA liquid drops.
"My doctor mentioned my liver enzymes were slightly elevated. I started OLVA and cleaned up my diet. At my three-month follow-up, my numbers had improved noticeably. I'll never go back to capsules."
"I tried four different milk thistle products over two years — all capsules, none noticeable. Three days into OLVA, my afternoon energy completely changed."
"The ingredient list is genuinely clean — I check everything before buying. No fillers, no junk. Just what your liver needs. Rare in this space."
"I expected the drops to taste harsh. They're mild and easy. But the taste isn't why I keep reordering — it's how I feel after two months. Lighter. More energized."
SCIENTIFIC REFERENCES
- Abenavoli, L., et al. "Milk thistle in liver diseases: past, present, future." Phytotherapy Research, 2010.
- Anand, P., et al. "Bioavailability of curcumin: problems and promises." Molecular Pharmaceutics, 2007.
- Shoba, G., et al. "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers." Planta Medica, 1998.
- Younossi, Z.M., et al. "Global epidemiology of nonalcoholic fatty liver disease — meta-analytic assessment of prevalence, incidence, and outcomes." Hepatology, 2016.
This article is sponsored editorial content presented by TRYOLVA and reflects one healthcare professional's personal perspective and account, shared for informational and educational purposes. It is not medical advice, and it does not replace consultation with your own physician — always talk to your doctor before starting any new supplement, especially if you take prescription medication or have an existing liver condition.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary.